Maternal age-specific risks for trisomies at 9-14 weeks' gestation
- PMID: 7971755
- DOI: 10.1002/pd.1970140706
Maternal age-specific risks for trisomies at 9-14 weeks' gestation
Abstract
This study provides data on the incidence of fetal trisomies 21, 18, and 13 at 9-14 weeks' gestation in women aged 35-45 years and estimates of maternal age-specific risks in women aged 20-45 years. Our data from 5814 singleton pregnancies undergoing first-trimester karyotyping for the sole indication of maternal age > or = 35 years were combined with those from two previous reports and the incidence of the trisomies was calculated from a total of 15,793 pregnancies. Comparison of incidences at 9-14 weeks' gestation with published data at 15-20 weeks' gestation and in livebirths demonstrated that at birth the maternal age-specific incidence of trisomy 21 is 33 per cent lower than at 15-20 weeks' gestation and 54 per cent lower than at 9-14 weeks' gestation. Furthermore, the relative frequency of trisomies 18 and 13 decreases from 30 per cent at 9-14 weeks to 22 per cent at 15-20 weeks and 14 per cent at birth.
Similar articles
-
Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.Br J Obstet Gynaecol. 1994 Sep;101(9):782-6. doi: 10.1111/j.1471-0528.1994.tb11946.x. Br J Obstet Gynaecol. 1994. PMID: 7947527
-
Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies.Prenat Diagn. 1991 Nov;11(11):847-57. doi: 10.1002/pd.1970111106. Prenat Diagn. 1991. PMID: 1721713
-
Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.Ultrasound Obstet Gynecol. 2016 Jun;47(6):698-704. doi: 10.1002/uog.15851. Epub 2016 Apr 25. Ultrasound Obstet Gynecol. 2016. PMID: 26743020
-
Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.Br J Obstet Gynaecol. 1995 Feb;102(2):127-32. doi: 10.1111/j.1471-0528.1995.tb09065.x. Br J Obstet Gynaecol. 1995. PMID: 7538782 Review.
-
Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation.Ultrasound Obstet Gynecol. 1995 Oct;6(4):250-5. doi: 10.1046/j.1469-0705.1995.06040250.x. Ultrasound Obstet Gynecol. 1995. PMID: 8590187 Review.
Cited by
-
Nuchal translucency: an ultrasound marker for fetal chromosomal abnormalities.Sao Paulo Med J. 2001 Jan 4;119(1):19-23. doi: 10.1590/s1516-31802001000100006. Sao Paulo Med J. 2001. PMID: 11175621 Free PMC article.
-
Clinical and Economic Impact of Adopting Noninvasive Prenatal Testing as a Primary Screening Method for Fetal Aneuploidies in the General Pregnancy Population.Fetal Diagn Ther. 2019;45(6):413-423. doi: 10.1159/000491750. Epub 2018 Aug 21. Fetal Diagn Ther. 2019. PMID: 30130800 Free PMC article.
-
Introducing cell-free DNA noninvasive testing in a Down syndrome public health screening program: a budget impact analysis.Cost Eff Resour Alloc. 2020 Nov 4;18(1):49. doi: 10.1186/s12962-020-00245-5. Cost Eff Resour Alloc. 2020. PMID: 33292318 Free PMC article.
-
Prenatal, neonatal and postnatal factors and the developmental defects of dental enamel.Rev Paul Pediatr. 2023 Aug 25;42:e2022226. doi: 10.1590/1984-0462/2024/42/2022226. eCollection 2023. Rev Paul Pediatr. 2023. PMID: 37646751 Free PMC article.
-
Trisomy recurrence: a reconsideration based on North American data.Am J Hum Genet. 2004 Sep;75(3):376-85. doi: 10.1086/423331. Epub 2004 Jul 8. Am J Hum Genet. 2004. PMID: 15248154 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources